归创通桥医疗科技股份有限公司（股票代码：02190）于2026年7月13日发布公告，披露翌日报表相关信息。公告显示，公司于当日在香港联交所场内回购普通股5.90万股，占回购前公司已发行股份（不包括库藏股）的约0.0178%。本次回购每股最高价格为19.50港元、最低价格为18.94港元，合计支付约113.25万港元。
回购完成后，公司已发行股份（不包括库藏股）数量由323,721,613股降至323,662,613股，库藏股数量由12,629,631股增加至12,688,631股，已发行股本总数维持336,351,244股。公告同时披露，2026年5月13日通过的股份购回授权总数量为32,715,311股，截至目前公司已累计于交易所及其他平台回购股票3,541,500股，占授权购回时已发行股份（不包括库藏股）总数的约1.0574%。
公司声明，本次回购已遵循香港联合交易所有限公司证券上市规则及相关法律法规的规定，并按要求履行了相关审批及披露程序。公告由董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.